Skip to content
Clinical Trials – home
Horizon Therapeutics Ireland Designated Activity Company
Sponsor

Horizon Therapeutics Ireland Designated Activity Company

Ireland Pottery Road, Dun Laoghaire, A96 F2A8 Dublin, Ireland

About the sponsor

Clinical research includes idiopathic pulmonary fibrosis and lung involvement linked to diffuse cutaneous systemic sclerosis, with attention to respiratory function and disease-related decline.

  • Idiopathic pulmonary fibrosis
  • Forced vital capacity
  • Systemic sclerosis-associated lung disease

The sponsor’s portfolio reflects interest in conditions where pulmonary fibrosis and connective tissue disease overlap.

About Specializations

Horizon Therapeutics Ireland Designated Activity Company runs clinical trials in conditions such as Sjogren's syndrome, Systemic scleroderma, Neuromyelitis optica spectrum disorder, Dermatomyositis, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

11 clinical trials

Countries:FranceFrance
  • Participants:0–17 years
  • Substances:Inebilizumab
  • Sponsor:Horizon Therapeutics Ireland Designated Activity Company
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Dazodalibep
  • Sponsor:Horizon Therapeutics Ireland Designated Activity Company
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Dazodalibep
  • Sponsor:Horizon Therapeutics Ireland Designated Activity Company
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Fipaxalparant
  • Sponsor:Horizon Therapeutics Ireland Designated Activity Company

Systemic scleroderma

Not recruiting
Investigational
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Fipaxalparant
  • Sponsor:Horizon Therapeutics Ireland Designated Activity Company

Sjogren's syndrome

Not recruiting
Investigational
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Vib1116
  • Sponsor:Horizon Therapeutics Ireland Designated Activity Company
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Daxdilimab
  • Sponsor:Horizon Therapeutics Ireland Designated Activity Company
Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Inebilizumab
  • Sponsor:Horizon Therapeutics Ireland Designated Activity Company

Myasthenia gravis

Not recruiting
Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Inebilizumab
  • Sponsor:Horizon Therapeutics Ireland Designated Activity Company
Investigational
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Fipaxalparant
  • Sponsor:Horizon Therapeutics Ireland Designated Activity Company
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Daxdilimab
  • Sponsor:Horizon Therapeutics Ireland Designated Activity Company

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.